CVSA — Covista Share Price
Last trade - 00:00- $4.31bn
- $4.56bn
- $1.95bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 13.64 | ||
| PEG Ratio (f) | 1.27 | ||
| EPS Growth (f) | 12% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.98 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 10.97 | ||
| Price to Sales | 2.2 | ||
| EV to EBITDA | 10.53 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 15.67% | ||
| Return on Equity | 18.57% | ||
| Operating Margin | 19.37% | ||
Financial Summary
| Year End 30th Jun | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1,381.84 | 1,450.83 | 1,584.65 | 1,788.29 | 1,954.09 | 2,064.8 | 2,193.37 | 16.79% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +50.96 | +49.48 | +26.84 | +12.65 | +10.61 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.
Directors
- Lisa Wardell CHM (52)
- Stephen Beard PRE (50)
- Robert Phelan CFO (56)
- John Danaher CEX
- Roger Mckinney CEX
- Nancy Johnson CHO
- Maurice Herrera SVP
- Douglas Beck SVP (54)
- James Bartholomew SVP
- Steven Tom SVP (36)
- William Burke LED (62)
- Charles DeShazer IND (62)
- Mayur Gupta IND (44)
- Donna Hrinak IND (70)
- Georgette Kiser IND (53)
- Lyle Logan IND (62)
- Michael Malafronte IND (47)
- Sharon O'Keefe IND (69)
- Kenneth Phelan IND (62)
- Last Annual
- June 30th, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- August 3rd, 1987
- Public Since
- November 14th, 1995
- No. of Shareholders
- 147
- No. of Employees
- 4,736
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- New York Stock Exchange
- Shares in Issue
- 33,860,208
- Address
- 233 S. Wacker Drive, Suite 800, CHICAGO, 60606
- Web
- https://www.covista.com
- Phone
- +1 3026365400
- Contact
- Jay Spitzer
- Auditors
- PricewaterhouseCoopers LLP
Latest News for CVSA
Upcoming Events for CVSA
Q1 2027 Covista Inc. Earnings Release
Q1 2027 Covista Inc. Earnings Call
Covista Inc. Annual Shareholders Meeting
Covista Inc. Annual Shareholders Meeting
Q2 2027 Covista Inc. Earnings Release
Similar to CVSA
Boyd Services
New York Stock Exchange
Bright Horizons Family Solutions
New York Stock Exchange
Carriage Services
New York Stock Exchange
Church & Dwight
New York Stock Exchange
The Clorox
New York Stock Exchange
FAQ
As of Today at 02:06 UTC, shares in Covista are trading at $127.24. This share price information is delayed by 15 minutes.
Shares in Covista last closed at $127.24 and the price had moved by -14.39% over the past 365 days. In terms of relative price strength the Covista share price has underperformed the S&P500 Index by -26.71% over the past year.
The overall consensus recommendation for Covista is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCovista does not currently pay a dividend.
Covista does not currently pay a dividend.
Covista does not currently pay a dividend.
To buy shares in Covista you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $127.24, shares in Covista had a market capitalisation of $4.31bn.
Here are the trading details for Covista:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: CVSA
Based on an overall assessment of its quality, value and momentum Covista is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Covista is $158.75. That is 24.76% above the last closing price of $127.24.
Analysts covering Covista currently have a consensus Earnings Per Share (EPS) forecast of $9.05 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Covista. Over the past six months, its share price has underperformed the S&P500 Index by -0.93%.
As of the last closing price of $127.24, shares in Covista were trading +7.22% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Covista PE ratio based on its reported earnings over the past 12 months is 13.64. The shares last closed at $127.24.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Covista's management team is headed by:
- Lisa Wardell - CHM
- Stephen Beard - PRE
- Robert Phelan - CFO
- John Danaher - CEX
- Roger Mckinney - CEX
- Nancy Johnson - CHO
- Maurice Herrera - SVP
- Douglas Beck - SVP
- James Bartholomew - SVP
- Steven Tom - SVP
- William Burke - LED
- Charles DeShazer - IND
- Mayur Gupta - IND
- Donna Hrinak - IND
- Georgette Kiser - IND
- Lyle Logan - IND
- Michael Malafronte - IND
- Sharon O'Keefe - IND
- Kenneth Phelan - IND